HSBC Holdings’s Novo Nordisk NVO Stock Holding History

HSBC Holdings’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-80,000	Closed	-$4.09M	–	3127
2025 Q4	$4.09M	Buy	80,000 +71,500	+841%	+$3.66M	﹤0.01%	1289
2025 Q3	$472K	Sell	8,500 -10,000	-54%	-$585K	﹤0.01%	2134
2025 Q2	$1.28M	Hold	18,500	–	–	﹤0.01%	1679
2025 Q1	$1.28M	Sell	18,500 -131,500	-88%	-$10.9M	﹤0.01%	1645
2024 Q4	$12.9M	Buy	+150,000	New	+$16.2M	0.01%	853
2016 Q4	–	Sell	-2,000	Closed	-$42K	–	2762
2016 Q3	$42K	Buy	+2,000	New	+$49.6K	﹤0.01%	2020

Other funds holding NVO

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return

HSBC Holdings's NVO Position: Q1 2026 in Review

HSBC Holdings increased its Novo Nordisk (NVO) stake by 96% in Q1 2026, buying an estimated $20.9M and bringing the position to 899,804 shares worth $32.7M. The position accounts for 0.02% of the portfolio, ranked #620.

HSBC Holdings first reported a position in NVO in Q3 2014 and has held it in 47 quarters since. The position peaked at $55M in Q2 2023. 1,272 funds tracked by Wall St. Rank hold NVO as of Q1 2026.

HSBC Holdings held 899,804 shares of Novo Nordisk worth $32.7M as of Q1 2026.
HSBC Holdings bought 440,571 Novo Nordisk shares in Q1 2026, an estimated $20.9M.
Novo Nordisk made up 0.02% of HSBC Holdings's portfolio in Q1 2026, its #620 holding.
HSBC Holdings first reported a position in Novo Nordisk in Q3 2014 and has held it in 47 quarters since.
HSBC Holdings's Novo Nordisk position peaked at $55M in Q2 2023.
1,272 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.